AG Pharma
AG Pharma is the adult-health division of Italian pharmaceutical group Dicofarm, developing and marketing probiotics, laxatives, vitamins, phytotherapy supplements, and medical devices through pharmacies in Italy and via subsidiaries in Poland, Spain, and Romania.
- Company typePrivate
- Founded2002
- HeadquartersRome, Italy
- Headcount101–250
- GTM typeB2C
- OfferingHardware or Manufacturing
What AG Pharma does
AG Pharma (AGPharma S.r.l.) is the adult-health nutraceutical and medical device arm of Italian pharmaceutical group Dicofarm. Founded in 2002 as a spin-off from Dicofarm (originally established in 1977) to extend pediatric expertise to adult therapeutics, the company develops and markets a portfolio of food supplements and CE-marked medical devices distributed primarily through Italian pharmacies, with international reach via wholly-owned subsidiaries in Poland, Spain, and Romania and a dedicated export/co-marketing channel.
AG Pharma firmographics
Firmographics- Name
- AG Pharma
- Legal name
- Dicofarm Ltd
- Website
- https://agpharma.eu
- Company type
- Private
- Founded year
- 2002
- Operating status
- Acquired
- Headcount range
- 101–250 employees
- Short description
- AG Pharma is the adult-health division of Italian pharmaceutical group Dicofarm, developing and marketing probiotics, laxatives, vitamins, phytotherapy supplements, and medical devices through pharmacies in Italy and via subsidiaries in Poland, Spain, and Romania.
- Ownership category
- akta.pro rank
AG Pharma industry classification
Industry- Product category
- Nutraceuticals and Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Probiotics & Digestive Health Supplements (CRADAGAF)
- akta.pro secondary industries
- Herbal & Botanical Supplements (CRADAGAD), Vitamins & Minerals (Single Nutrients) (CRADAGAB)
Keywords
Where AG Pharma is headquartered
LocationHeadquarters
- HQ city
- Rome
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
AG Pharma business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Products Sales: Sale of pharmaceutical products including medical devices (vaginal moisturizers, laxatives like AGpeg products) and prescription/dispensing medicines through pharmacies
- Food Supplements Sales: Sale of food supplements including probiotics, vitamins, minerals, lactoferrin, phytotherapy, and dietary fibers through pharmacies and retail
- Export and Co-Marketing: Products available for export or co-marketing arrangements in international markets
Distribution channels3 records
Marketing channels4 records
AG Pharma product offering
Product offeringCore offering
AG Pharma develops, manufactures and distributes pharmaceutical products, food supplements and CE-marked medical devices for adult consumers. Its portfolio spans probiotics (Dicoflor line with L. rhamnosus GG), osmotic laxatives (AGpeg Macrogol 3350 products), vitamins and minerals (Dicofer iron, Rock D3), lactoferrin supplements (Elleffe), phytotherapy products (Dicalmir herbal teas, Zenzeril ginger, Ivucran cranberry), dietary fibers (Realim, Dicoplus 100) and vaginal medical devices (DicoElle Repair with hyaluronic acid). Products are sold primarily through pharmacies in Italy and via international subsidiaries and export/co-marketing partners abroad.
Product overview
AG Pharma (now merged into Dicofarm as of February 2026) operates as an adult health pharmaceutical company offering a diverse portfolio of food supplements and medical devices. The product range centers on gastrointestinal health (probiotics including Dicoflor line with L. rhamnosus GG and L. plantarum, laxatives including AGpeg Macrogol-based products, and DicoSim simethicone products), nutritional supplements (vitamins and minerals including Dicofer iron supplements, Rock D3 calcium/vitamin D/K2, and Vita D Fast), lactoferrin supplements (Elleffe 100 line), phytotherapy products (Dicalmir herbal teas, Zenzeril ginger supplements, Ivucran cranberry, Agires 50 resveratrol), and vaginal health (DicoElle Repair hyaluronic acid suppositories). Products are distributed across therapeutic categories including probiotics (10 products), laxatives (7 products), phytotherapy (5 products), vitamins and minerals (4 products), dietary fibers (2 products), and lactoferrin (2 products), with some items classified as medical devices bearing CE marking.
Differentiator
Problem solved
Functional benefit
Brands
- Dicoflor: Product line for intestinal microflora balance and probiotics
- DicoElle
- AGpeg
- Elleffe
- DicoSim
- Dicalmir
Products and services
- DicoSim Plus
Companies that use AG Pharma
Customer profileSegments2 records
Ideal customer profiles3 records
AG Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
AG Pharma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Dicofarm PolskacoreSubsidiary established in 2006 to serve the Polish market. Dicofarm Polska is described as a leader in nutraceuticals in Poland.
Scale indicators1 record
Recent moves7 records
Expansion highlights2 records
AG Pharma competitors and assessment
Company assessmentDirect peers
- Norgine: European specialty pharma focused on gastroenterology, with leading Macrogol-based laxative and bowel-preparation products (Movicol/Moviprep) that directly compete with AG Pharma's AGpeg Macrogol 3350 line for constipation and diagnostic bowel cleansing.
- Yakult Honsha: Global probiotic brand built around Lactobacillus strains; directly comparable to AG Pharma's Dicoflor L. rhamnosus GG franchise as a consumer-facing probiotic specialist sold through pharmacy and retail channels.
- Aboca: Italian herbal medicine and natural-health company specializing in phytotherapy, food supplements, and medical devices — directly comparable to AG Pharma's Dicalmir, Zenzeril, and Ivucran phytotherapy line and natural-products positioning.
- Alfasigma: Italian pharma company with a heavy OTC, supplement, and gastroenterology portfolio sold through Italian pharmacies — closely matching AG Pharma's channel, geography, and therapeutic focus including PEG-based laxatives and probiotics.
Emerging players
- Chr. Hansen (Novonesis): Global leader in probiotic strain development and B2B supply to supplement and dairy brands; comparable to AG Pharma's L. rhamnosus GG probiotic franchise at the upstream strain and ingredient layer, though operating on a B2B rather than consumer-brand model.
Broad incumbents
- Angelini Pharma: Italian privately held pharma with consumer health, women's health, and OTC supplements across European markets — overlaps with AG Pharma in therapeutic areas and pharmacy-led distribution model.
- Menarini: Large Italian pharmaceutical group with broad OTC, consumer health, and women's health portfolios distributed through Italian and European pharmacies — comparable to AG Pharma in channel and category breadth, though at significantly larger scale.
- Bayer Consumer Health: Global OTC and dietary-supplement powerhouse (Elevit, Berocca, Canesten, Bepanthen) with deep European pharmacy penetration and active women's health and gut-health categories that overlap with AG Pharma's Elleffe, Dicoflor, and DicoElle lines.
- Recordati: Established Italian pharma with a consumer health and specialty pharma portfolio, including gastroenterology and women's health products distributed across Europe — comparable in therapeutic breadth and Italian heritage.
Regional players
- Named Group (Named Sport / Salugea): Italian nutraceutical and supplement company distributed primarily through pharmacies and para-pharmacies in Italy — comparable scale and channel to AG Pharma but with a heavier focus on sports nutrition and dermatology-adjacent categories.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
AG Pharma social profiles
Digital presenceAG Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
AG Pharma leadership team
Management profileNumber of profiles
Profiles1 record
AG Pharma subsidiaries and ownership
Company hierarchySubsidiaries1 record
AG Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AG Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AG Pharma
What does AG Pharma do?
AG Pharma develops, manufactures and distributes pharmaceutical products, food supplements and CE-marked medical devices for adult consumers. Its portfolio spans probiotics (Dicoflor line with L. rhamnosus GG), osmotic laxatives (AGpeg Macrogol 3350 products), vitamins and minerals (Dicofer iron, Rock D3), lactoferrin supplements (Elleffe), phytotherapy products (Dicalmir herbal teas, Zenzeril ginger, Ivucran cranberry), dietary fibers (Realim, Dicoplus 100) and vaginal medical devices (DicoElle Repair with hyaluronic acid). Products are sold primarily through pharmacies in Italy and via international subsidiaries and export/co-marketing partners abroad.
Is AG Pharma a public or private company?
AG Pharma is a private company. It is classified as corporate owned and is currently acquired.
When was AG Pharma founded?
AG Pharma was founded in 2002. It employs 101 to 250 people.
Where is AG Pharma based?
AG Pharma is headquartered in Rome, Italy, in the Europe region.
How does AG Pharma make money?
Three revenue lines are on record. Pharmaceutical Products Sales are the primary driver. The others are food Supplements Sales and export and Co-Marketing.
Who are AG Pharma's main competitors?
Direct peers on record are Norgine, Yakult Honsha, Aboca and Alfasigma. Chr. Hansen (Novonesis) is listed as an emerging player. Broad incumbents are Angelini Pharma, Menarini, Bayer Consumer Health and Recordati. Named Group (Named Sport / Salugea) is listed as a regional player.
Does AG Pharma have an API?
No public API is recorded for AG Pharma.
What industry is AG Pharma in?
AG Pharma's product category is Nutraceuticals and Pharmaceutical Manufacturing. Its primary akta.pro industry code is CRADAGAF, Probiotics & Digestive Health Supplements, with a secondary code of CRADAGAD, Herbal & Botanical Supplements. Its NAICS code is 325412 and its SIC code is 2834.